An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz,

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis  Fuad M. Baroody, MD, David Brown, MD,
Allergen immunotherapy: A practice parameter third update
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses  Stephen R. Durham,
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,
Pharmacologic rationale for treating allergic and nonallergic rhinitis
Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.
Fatty acids, inflammation, and asthma
Proximal signaling events in FcɛRI-mediated mast cell activation
Advances in food allergy in 2015
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses  Stephen R. Durham,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population  Hui.
Is 9 more than 2 also in allergic airway inflammation?
Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I
Fatty acids, inflammation, and asthma
Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: Patterns of care, resource use, and costs  Cheryl S. Hankin, PhD, Linda.
Robert G. Hamilton, PhD, John Oppenheimer, MD 
The enigma of IgE+ B-cell memory in human subjects
Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients  William W. Busse, MD, Sally E. Wenzel, MD, Eli O. Meltzer,
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis  Fuad M. Baroody, MD, David Brown, MD,
The National Biome Initiative: An allergy perspective
Reply Journal of Allergy and Clinical Immunology
The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria  Tse Wen Chang, PhD, Christina Chen, BS, Chien-Jen.
Peter M. Wolfgram, MD, David B. Allen, MD 
Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind,
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
Reply Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, Michael Tankersley, MD 
A review of the current guidelines for allergic rhinitis and asthma
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Allergen-specific immunotherapy with recombinant grass pollen allergens  Marek Jutel, MD, Lothar Jaeger, MD, Roland Suck, PhD, Hanns Meyer, Dipl Math,
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma  Kawa Amin, PhD, Christer Janson, MD, PhD, Ilkka Harvima, MD,
John A. Eckman, MD, Patricia M
The role of the T cell in asthma
What is an “eosinophilic phenotype” of asthma?
Cephalosporin Side Chain Cross-reactivity
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Cockroach allergens: Coping with challenging complexity
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab  Donald W. MacGlashan,
Cagri Yildirim-Toruner, MD, Betty Diamond, MD 
Risk of oral food challenges
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency  Marcel Levi, MD,
Reply Journal of Allergy and Clinical Immunology
Anaphylaxis Journal of Allergy and Clinical Immunology
Thunderstorm-related asthma attacks
An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz,
Measles and immunomodulation
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis  Warner Carr, MD, Jonathan Bernstein, MD, Phil Lieberman,
Kinase inhibitors in clinical practice: An expanding world
The effects of an H3 receptor antagonist (PF ) with fexofenadine on reducing allergic rhinitis symptoms  Jeffrey R. Stokes, MD, Francisco A. Romero,
Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule 
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Itching as a systemic disease
Presentation transcript:

An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment  Eli O. Meltzer, MD, Robert B. Berkowitz, MD, Elliott B. Grossbard, MD  Journal of Allergy and Clinical Immunology  Volume 115, Issue 4, Pages 791-796 (April 2005) DOI: 10.1016/j.jaci.2005.01.040 Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 1 Allergen cross-binding to IgE bound to Fcε receptor on mast cell initiates lyn phosphorylation of receptor and Syk activation with downstream effects that include degranulation as well as lipid mediator and cytokine synthesis and release. Journal of Allergy and Clinical Immunology 2005 115, 791-796DOI: (10.1016/j.jaci.2005.01.040) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 2 Park study schedule of events. bid, Two times daily; ECG, electrocardiogram; SGA, subject global assessment; SGTR, subject global therapeutic response. Journal of Allergy and Clinical Immunology 2005 115, 791-796DOI: (10.1016/j.jaci.2005.01.040) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 3 Comparison of improvement (%) in individual symptoms and overall GSC between patients receiving R112 and those receiving placebo. Journal of Allergy and Clinical Immunology 2005 115, 791-796DOI: (10.1016/j.jaci.2005.01.040) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions

Fig 4 GSC score over time; park day 1 and 2. Journal of Allergy and Clinical Immunology 2005 115, 791-796DOI: (10.1016/j.jaci.2005.01.040) Copyright © 2005 American Academy of Allergy, Asthma and Immunology Terms and Conditions